The careful gathering of women’s health science
Peptide therapy, decoded for women.
Editorial comparisons of peptide telehealth providers — credentials, pharmacy sourcing, pricing, states served — evaluated for women. Plus a free guide to bring to your first consult.
Peptides
10
Providers
4
Articles
10
The Anthivera approach
A research-grounded approach to peptide therapy for women.
We compare what the FDA, the regulatory record, and the peer- reviewed literature actually say — through the lens of a woman's body. So you arrive at any consult informed.
10
Peptides reviewed
4
Providers compared
10
Articles, all cited
Monthly
Editorial updates
Start where you are
Browse by goal.
The six reasons women come to peptide therapy. Each opens to the relevant peptides, the evidence behind them, and the regulatory status — so you arrive at any provider conversation already informed.
PERIMENOPAUSE CARE.
Perimenopause
GH-axis peptides, kisspeptin, collagen — what helps and what's still preliminary.
LIBIDO & PT-141.
Libido
PT-141 / Vyleesi — the FDA-approved option for women, and what to know about it.
SKIN & COLLAGEN.
Skin & collagen
GHK-Cu and collagen peptides — topical vs. oral, evidence and expectations.
RESTORATIVE SLEEP.
Sleep
GH-axis peptides and slow-wave sleep — what's plausible vs. what's proven.
RECOVERY & STRENGTH.
Recovery & joint
BPC-157, TB-500 — strong preclinical, limited human data, and the 2026 regulatory shift.
METABOLIC HEALTH.
Metabolic & GLP-1
Semaglutide — FDA-approved for weight management; widely prescribed via telehealth.
Research-grounded
We cite the FDA, peer-reviewed studies, and the regulatory record — not influencer hype.
Vendor-neutral
We compare; we don't recommend treatment. If a provider is featured, you'll know why — and how we make money.
Written for women
Every peptide, every provider, evaluated through the lens of perimenopause, libido, skin, sleep, and recovery in a woman's body.
Editorially evaluated
Where to start your search.
Three peptide-telehealth providers we've evaluated for women — based on credentials, pharmacy sourcing, pricing, and states served. Editorial ratings come from those criteria alone, never from commercial relationships.
Solace MD
4.6/5Higher price band, faster shipping, more personal care — the right fit if cost isn't the primary constraint.
- Price
- $110–$340/mo
- States
- 7 served
Read the full review
Evergreen Women's Health
4.5/5Strongest fit for perimenopausal women seeking continuity of care — pairs hormone testing with peptide protocols.
- Price
- $89–$249/mo
- States
- 10 served
Read the full review
Northstar Peptide Co.
4.2/5Specialty: recovery and skin peptides. Less hormone-focused than competitors, but a tighter, more specialized catalog.
- Price
- $75–$220/mo
- States
- 8 served
Read the full review
Why Anthivera
The editorial difference.
Most peptide content online is written to convert, not to inform. Here's how Anthivera differs from the typical clinic-funded funnel a woman lands on.
| Dimension | Anthivera | Typical peptide clinic |
|---|---|---|
| Who it's written for | Women — perimenopause, libido, skin, sleep, recovery | General audience (mostly male-coded biohacker copy) |
| Provider recommendations | Compared on six published criteria, no paid placement | Whoever pays the most for the ad slot |
| Evidence handling | Every claim cited and dated; regulatory status surfaced | Influencer-style claims, often outdated, rarely sourced |
| What you take away | A printable guide to bring to a licensed clinician | A signup form for a consult you didn't compare |
How it works
Four steps, every time.
Find your goal, read the evidence, compare providers, talk to a clinician. The website carries the first three; the free guide carries the fourth.
- 01
Find your goal
Perimenopause, libido, skin, sleep, recovery, metabolic. Each goal opens the relevant peptides and evidence.
- 02
Read the evidence
FDA status, study citations, regulatory context. Every claim dated; every source linked.
- 03
Compare providers
Telehealth providers evaluated on six editorial criteria — credentials, pharmacy, pricing, states served.
- 04
Talk to a clinician
Print the free guide, bring it to a licensed provider. The decision stays with you and your doctor.
Peptide in focus
PT-141 (Bremelanotide)
FDA-approvedLibidoFDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women — the strongest evidence-based peptide option in this category.
Latest writing
New and recently updated.
- recovery1 min
Peptides for Recovery & Joint Health: BPC-157 Explained
BPC-157 is one of the most-discussed recovery peptides. Here's what the research shows, what the 2026 FDA changes mean, and an honest look at the evidence gaps.
Draft - hormone1 min
Compounded vs. Research Peptides: What's Legal and What's Safe in 2026
The difference between a compounded peptide prescription and a gray-market 'research' peptide is the difference between regulated and unregulated. Here's what changed in 2026.
Draft - skin1 min
Peptides for Skin & Collagen: GHK-Cu and What It Does
GHK-Cu is one of the most-searched skincare peptides. Here's what the research shows for skin, collagen, and aging — and the difference between topical and injectable.
Draft
A note from the editors
We started Anthivera because the peptide conversation for women is too important to leave to algorithms and unsourced influencers. Every article is researched, cited, and dated. Every provider review is independent.
And when we say women, we mean trans women, cis women, and anyone navigating these concerns from a woman-shaped life. If we ever fall short of that standard, please tell us.
— The Anthivera editors
Join Anthivera Insider.
One careful, research-backed email a week on peptide therapy for women. No hype. Unsubscribe anytime.